
SNWV Stock Forecast & Price Target
SNWV Analyst Ratings
Bulls say
SANUWAVE Health Inc. reported a substantial revenue growth of 60% year-over-year, reaching $32.6 million, primarily driven by increased sales of its systems and consumables. The company also achieved a significant improvement in Adjusted EBITDA, increasing by 28 percentage points to 22%, reflecting strong operational efficiency despite a modest rise in operating expenses to $6.4 million. This combination of robust sales growth and enhanced profitability metrics positions SANUWAVE favorably within the regenerative medicine market.
Bears say
The first quarter applicator usage for SANUWAVE Health was modestly down compared to the previous quarter, primarily attributed to the typical seasonal behavior of patients delaying treatments due to resetting insurance deductibles. Additionally, the company faces fundamental challenges including margin compression, competitive pressures, reduced productivity among sales representatives, and potential manufacturing setbacks, all of which could adversely affect financial performance. These factors collectively contribute to a negative outlook on SANUWAVE Health's stock, as they suggest ongoing operational and market vulnerabilities.
This aggregate rating is based on analysts' research of SANUWAVE Health Inc and is not a guaranteed prediction by Public.com or investment advice.
SNWV Analyst Forecast & Price Prediction
Start investing in SNWV
Order type
Buy in
Order amount
Est. shares
0 shares